China's Global Market Share in Medical Devices: A Focus on Surgical Robots and Export Strategies

Tuesday, 27 August 2024, 23:00

China's global market share in medical devices is expanding, particularly in surgical robots, as exports rise despite looming trade barriers. The country's medical-device makers are leveraging competitive pricing and advancing R&D to capture overseas markets. Growing exports, especially to Europe and the Middle East, indicate that Chinese firms are adapting to international demands while facing challenges from tariffs and geopolitical tensions.
South China Morning Post
China's Global Market Share in Medical Devices: A Focus on Surgical Robots and Export Strategies

China's Expanding Medical Device Market

Chinese medical-device makers are increasingly looking to expand overseas markets, particularly in the high-end sector, including surgical robots. With exports surging due to competitive pricing and effective R&D, companies are shifting focus away from domestic struggles. This strategy is evident as exports of class III devices reached US$3.9 billion in just the first seven months of the year, now representing 32.37 percent of total exports.

Impact of Tariffs and Trade Barriers

  • The United States remains a primary destination for Chinese medical device exports, making up 18.47 percent of the total.
  • Despite potential trade barriers and tariffs impacting growth, the demand for affordable high-quality medical products in developing regions is rising.
  • Geopolitical risks include investigations by the EU into market access and new tariffs imposed by the US on over 100 Chinese medical products.

The Future of Chinese Medical Exports

The forecast indicates that China's global market share of advanced medical technology products will continue to grow, driven by robust exports and substantial government support. Companies are capitalizing on their ability to meet international quality standards while maintaining cost advantages over their Western counterparts. Expanding into regions prioritizing low costs positions them well amidst increasing competition globally.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe